Lexaria Bioscience CORP S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Lexaria Bioscience Corp. filed an S-1/A registration statement for the resale of up to 2.76 million common shares by selling stockholders, with potential proceeds from warrant exercises earmarked for R&D.
NASDAQ
Lexaria Bioscience Corp. filed an S-1 registration statement for the resale of up to 2,760,000 common shares by selling stockholders, with the company not receiving direct proceeds from these sales but potentially from warrant exercises.
NASDAQ
S-1: Lexaria Bioscience Corp. Files for Resale of 2,917,032 Common Shares Issuable Upon Warrant Exercise
Lexaria Bioscience Corp. has filed a registration statement for the resale of up to 2,917,032 shares of its common stock by a selling stockholder, which are issuable upon the exercise of a warrant issued on April 30, 2024.
NASDAQ
Lexaria Bioscience Corp. has filed a registration statement for the resale of up to 1,612,989 shares of its common stock by selling stockholders, which are issuable upon the exercise of outstanding warrants.